Irritable Bowel Syndrome
Authors:
- Alexander C FordAFAlexander C Ford
- Brian E LacyBLBrian E Lacy
- Nicholas J TalleyNTNicholas J Talley
Top Cited Papers
- 29 June 2017
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 376 (26) , 2566-2578
Abstract
IBS affects 7 to 16% of the U.S. population, with subtypes characterized by diarrhea, constipation, or both. Patients may have a response to dietary modification, and an effective doctor–patient relationship may increase symptom control.Keywords
This publication has 74 references indexed in Scilit:
- ACG Clinical Guidelines: Diagnosis and Management of Celiac DiseaseAmerican Journal of Gastroenterology, 2013
- Stool characteristics and colonic transit in irritable bowel syndrome: evaluation at two time pointsScandinavian Journal of Gastroenterology, 2012
- A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With ConstipationAmerican Journal of Gastroenterology, 2012
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without ConstipationNew England Journal of Medicine, 2011
- Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel SyndromePLOS ONE, 2010
- Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2010
- The Yield of Colonoscopy in Patients With Non-Constipated Irritable Bowel Syndrome: Results From a Prospective, Controlled US TrialAmerican Journal of Gastroenterology, 2010
- Is Irritable Bowel Syndrome a Diagnosis of Exclusion? A Survey of Primary Care Providers, Gastroenterologists, and IBS ExpertsAmerican Journal of Gastroenterology, 2010
- Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?American Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsClinical Gastroenterology and Hepatology, 2008